Induction of cyclic flow reduction in the coronary, carotid, and femoral arteries of conscious, chronically instrumented dogs-Reference-Cited by-同舟云学术

Induction of cyclic flow reduction in the coronary, carotid, and femoral arteries of conscious, chronically instrumented dogs

Published:1988-08 Issue:1 Volume:20 Page:85-92
ISSN:0160-5402
Container-title:Journal of Pharmacological Methods
language:en
Short-container-title:Journal of Pharmacological Methods

Author:

Al-Wathiqui Mahmood H.,Hartman J.Craig,Brooks Harold L.,Warltier David C.

Publisher

Elsevier BV

Subject

Pharmacology

Reference14 articles.

1. Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet-aggregation;Aiken;Prostaglandins,1979

2. Cyclic blood flow variations induced by platelet-activating factor in stenosed canine coronary arteries despite inhibition of thromboxane synthetase, serotonin receptors, and α-adrenergic receptors;Apprill;Circulation,1985

3. Epinephrine reverses inhibition of cyclic reductions in flow in stenosed canine coronary arteries by serotonin2 or thromboxane A2/prostaglandin H2 receptor antagonists;Ashton,1987

4. Inhibition of cyclic flow variation in stenosed canine coronary arteries by thromboxane A2/prostaglandin H2 receptor antagonists;Ashton;Circ Res,1986

5. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries;Bush;Circulation,1984

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis,characterization and biological activities of nitrogen-containing Combretastatin A-4 derivatives;Medicinal Chemistry Research;2022-10-07

2. Blood Constituents and Safety Pharmacology: In Vitro and In Vivo Thrombosis and Hemostasis Assays;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2022

3. In Vivo or Ex Vivo Models of Thromobis;Drug Discovery and Evaluation: Pharmacological Assays;2016

4. In Vivo or Ex Vivo Models for Testing Thrombosis and Hemostasis;Drug Discovery and Evaluation: Pharmacological Assays;2015

5. Blood Constituents and Safety Pharmacology;Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays;2013